Hopman Mark
Chief Commercial Officer · 16 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-24 | BBNX | Beta Bionics, Inc. | Sale | 1,258 | $15.01 | $18,880.44 | filing |
| 2026-06-04 | BBNX | Beta Bionics, Inc. | Sale | 275 | $12.31 | $3,385.25 | filing |
| 2026-06-02 | BBNX | Beta Bionics, Inc. | Sale | 5,329 | $12.61 | $67,183.24 | filing |
| 2026-03-04 | BBNX | Beta Bionics, Inc. | Sale | 353 | $11.57 | $4,084.21 | filing |
| 2026-03-02 | BBNX | Beta Bionics, Inc. | Sale | 834 | $12.36 | $10,309.57 | filing |
| 2026-02-27 | BBNX | Beta Bionics, Inc. | Award | 109,105 | $0.00 | $0.00 | filing |
| 2025-12-04 | BBNX | Beta Bionics, Inc. | Sale | 2,061 | $30.66 | $63,192.32 | filing |
| 2025-12-02 | BBNX | Beta Bionics, Inc. | Sale | 856 | $29.34 | $25,111.53 | filing |
| 2025-09-05 | BBNX | Beta Bionics, Inc. | Sale | 11,411 | $20.56 | $234,656.95 | filing |
| 2025-09-05 | BBNX | Beta Bionics, Inc. | Option exercise | 11,411 | $5.10 | $58,196.10 | filing |
| 2025-09-04 | BBNX | Beta Bionics, Inc. | Sale | 6,818 | $19.97 | $136,180.00 | filing |
| 2025-09-04 | BBNX | Beta Bionics, Inc. | Option exercise | 4,093 | $5.10 | $20,874.30 | filing |
| 2025-09-04 | BBNX | Beta Bionics, Inc. | Option exercise | 656 | $5.10 | $3,345.60 | filing |
| 2025-09-02 | BBNX | Beta Bionics, Inc. | Sale | 848 | $18.86 | $15,995.99 | filing |
| 2025-08-19 | BBNX | Beta Bionics, Inc. | Sale | 16,158 | $16.61 | $268,376.30 | filing |
| 2025-08-19 | BBNX | Beta Bionics, Inc. | Option exercise | 16,158 | $5.10 | $82,405.80 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.